Faruk Boyaci

Faruk Boyaci

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 October 2013 in The International Journal of Cardiovascular Imaging
Verified
Journal Article
Closed access
PDF file
TGTayyar Gökdeniz
Tayyar Gökdeniz
EKEzgi Kalaycıoğlu
Ezgi Kalaycıoğlu
AAAhmet Çağrı Aykan
Ahmet Çağrı Aykan
IGİlker Gül
İlker Gül
FBFaruk Boyaci
Faruk Boyaci
MGMustafa Ozan Gürsoy
Mustafa Ozan Gürsoy

1 April 2022 in Journal of Arrhythmia
Verified
Journal Article
Open access
GAGökhan Aksan
Gökhan Aksan
AYAhmet Yanik
Ahmet Yanik
OYOsman Can Yontar
Osman Can Yontar
FBFaruk Boyaci
Faruk Boyaci
MUMelisa Uçar
Melisa Uçar
KSKorhan Soylu
Korhan Soylu
Aims: Galectin-3 is an inflammation biomarker that is associated with atrial fibrosis and plays a role in the development of atrial fibrillation (AF). Low voltage areas (LVAs) identified using an electroanatomical mapping system represent the presence of fibrotic tissue. The present study aimed to determine the relationship between coronary sinus (CS) serum sampling of galectin-3 levels and the presence and extent of LVA in patients with paroxysmal AF. Methods: A total of 115 consecutive paroxysmal AF patients underwent pulmonary vein isolation (PVI) included prospectively in the study. Voltage mapping was performed before PVI during sinus rhythm guided by multipolar high-density mapping catheter and LVAs were defined as regions where bipolar peak to peak voltage was <0.5 mV. Galectin-3 levels were measured via enzyme-linked immunosorbent assay. Results: CS serum sampling of galectin-3 levels was significantly higher in paroxysmal AF patients with LVA than those without LVA (16.5 +/- 3.7 ng/ml vs. 10.2 +/- 2.7 ng/ml, respectively, p < .001). CS serum sampling of galectin-3 levels was significantly higher in paroxysmal AF patients with moderate and severe LVA than in paroxysmal AF patients with mild LVA (17 +/- 3.5 ng/ml and 20.1 +/- 1.3 ng/ml vs. 13.3 +/- 2.3 ng/ml, respectively, p = .002). In the multivariate analysis female gender (odds ratio [OR] = 7.537, 95% confidence interval [CI]: 1.011-56.195; p = .049), left atrium volume (OR = 1.326, 95% CI: 1.052-1.67; p = .017), and CS serum sampling of galectin-3 levels (OR = 1.704, 95% CI: 1.169-2.483; p = .006) were significant and independent predictors for LVAs. Conclusion: In this study, we found that the CS serum sampling of galectin-3 levels increased with the extent of LVA and was an independent predictor for the presence of LVA.

7 December 2025 in BMC Cardiovascular Disorders
Verified
Journal Article
Open access
PDF file
AYAhmet Yanik
Ahmet Yanik
FBFaruk Boyaci
Faruk Boyaci
Mustafa Kursat SahinMustafa Kursat Sahin
Mustafa Kursat Sahin
Coronary collateral circulation (CCC) plays a crucial role in preserving myocardial perfusion in patients with chronic total occlusion (CTO) of the coronar

1 January 2021 in The Eurasian Journal of Medicine
Verified
Journal Article
Open access
FBFaruk Boyaci
Faruk Boyaci
MAMurat Akcay
Murat Akcay
EHEngin Hatem
Engin Hatem
AYAhmet Yanik
Ahmet Yanik
TGTayyar Gokdeniz
Tayyar Gokdeniz
Objective: Arterial stiffness is related to arteriolosclerotic diseases and is a marker of adverse cardiovascular events. Mitral annular calcification (MAC) is progressive calcium deposition on the posterior and inferior mitral annulus and is associated with atherosclerotic cardiovascular diseases. Cardio-ankle vascular index (CAVI) is a measurement technique used to estimate the degree of arterial stiffness without effect from blood pressure. The aim of this study is to research arterial stiffness using CAVI in patients with MAC. Materials and Methods: The study was cross-sectional and observational and included 98 patients with MAC confirmed by echocardiography who referred to the cardiology clinics and met study inclusion criteria and 38 controls without MAC. CAVI measurements were obtained by using the Vascular Screening System VaSera VS-1000 (Fukuda Denshi, Tokyo, Japan) device. Results: The two groups were similar in terms of demographic characteristics, including age, sex, hypertension, coronary artery disease, body surface area, and smoking (P > .05). Left atrial volume index was significantly higher in patients with MAC compared with the control group (P < .001). Right arm CAVI, left arm CAVI, and mean CAVI were significantly higher in the MAC group than the control group (P = .037, P = .005, and P = .014, respectively) and increased with MAC severity. There was a significant positive correlation between mean CAVI and MAC grade (r = 0.278, P = .001). Also, when ankle-brachial index (ABI) was measured with CAVI, left and right extremity ABI values were significantly lower in patients with MAC (P = .017 and P = .005, respectively). Conclusion: CAVI increased in all patients with MAC and associated with increasing grade of calcification.


28 August 2022 in Harran Üniversitesi Tıp Fakültesi Dergisi
Verified
Journal Article
Closed access
PDF file
FBFaruk Boyaci
Faruk Boyaci
MAMurat Akcay
Murat Akcay
TGTeyyar Gökdeni̇z
Teyyar Gökdeni̇z
Background: Neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR) are new systemic inflammation markers and predictor of adverse cardiovascular outcomes. Approximately 10% of patients with acute ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PPCI) have chronic total occlusion (CTO) of the non-infarct-related artery. The presence of concurrent CTO is associated with short- and long-term morbidity and mortality. Here, we aimed to investi-gate the relationship of NLR and PLO with coexistent CTO in STEMI patients.Materials and Methods: Ninety consecutive STEMI patients with concurrent CTO were included in the study group and 100 STEMI patients without CTO were included in the control group retrospectively. The relationship between inflammatory markers and concurrent CTO in STEMI was analyzed.Results: STEMI patients with concurrent CTO had increased NLR, PLR, C-reaktive protein and troponin while decreased glomerular filtration rate, left ventricular ejection fraction (LVEF) in comparison with patients without CTO. In multivariate analysis, NLR (p=0.002), PLR (p=0.042), CRP (p=0.002), hypertension (p<0.001), Hyperlipidemia (p=0.002) and LVEF (p=0.012) were found to be the independent predictors for the presence of concurrent CTO. In the ROC (Receiver Operating Characteristic) curve analysis, ≥ 5.6 and ≥ 164 cut-off values were determined for NLR and PLR in detecting concurrent CTO in STEMI.Conclusions: PLR and NLR, simple and easily calculated laboratory parameters, may permit prediction of concurrent CTO in patients with STEMI.Key Words: